These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Morphometric effects of long-term exposure to latanoprost. Cracknell KP, Grierson I, Hogg P. Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473 [Abstract] [Full Text] [Related]
3. Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study). Pfeiffer N, Grierson I, Goldsmith H, Appleton P, Hochgesand D, Winkgen A. Arch Ophthalmol; 2003 Jan; 121(1):23-31. PubMed ID: 12523881 [Abstract] [Full Text] [Related]
4. Histology and fine structure of the iris and outflow system following latanoprost therapy. Grierson I, Pfeiffer N, Cracknell KP, Appleton P. Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S176-84. PubMed ID: 12204715 [Abstract] [Full Text] [Related]
15. Latanoprost-induced iris color darkening: a case report with long-term follow-up. Camras CB, Neely DG, Weiss EL. J Glaucoma; 2000 Feb; 9(1):95-8. PubMed ID: 10708238 [Abstract] [Full Text] [Related]
16. The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change. Grierson I, Lee WR, Albert DM. Arch Ophthalmol; 1999 Mar; 117(3):394-6. PubMed ID: 10088822 [No Abstract] [Full Text] [Related]
17. Visualization of changes of the iris configuration after peripheral laser iridotomy in primary melanin dispersion syndrome using optical coherence tomography. Laemmer R, Mardin CY, Juenemann AG. J Glaucoma; 2008 Mar; 17(7):569-70. PubMed ID: 18854735 [Abstract] [Full Text] [Related]
18. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE. Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213 [Abstract] [Full Text] [Related]